Novel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis

• Joseph W. Jackson,

  Affiliation Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Meera V. Singh,

  Affiliation Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Vir B. Singh,

  Affiliation Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Letitia D. Jones,

  Affiliation Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Gregory A. Davidson,

  Current address: Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware, United States of America

  Affiliation Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Sara Ture,

  Affiliation Aab Cardiovascular Research Institute, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Craig N. Morrell,

  Affiliation Aab Cardiovascular Research Institute, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Giovanni Schifitto,

  Affiliation Department of Neurology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯
• Sanjay B. Maggirwar

  * E-mail: Sanjay_Maggirwar@URMC.Rochester.edu

  Affiliation Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America

  ⨯